-- China Petroleum & Chemical (HKG:0386, SHA:600028) or Sinopec reported a 28% jump in net profit in the first quarter to 17 billion yuan from 13.3 billion yuan a year earlier, according to filings with the Hong Kong and Shanghai bourses late Tuesday.
Earnings per share climbed to 0.141 yuan from 0.109 yuan.
Revenue fell 3.9% to 706.7 billion yuan from 735.4 billion yuan, the oil and gas company said.
Anteris Technologies (ASX:AVR) said it has secured US Medicare reimbursement eligibility for its global pivotal PARADIGM Trial under a Centers for Medicare and Medicaid Services (CMS) national coverage policy, according to a Wednesday Australian bourse filing.The PARADIGM Trial is evaluating the safety and effectiveness of the DurAVR transcatheter heart valve (THV) compared to transcatheter aortic valve replacements (TAVRs), with DurAVR THV being Anteris' product to treat aortic stenosis, a potentially life-threatening condition resulting from the narrowing of the aortic valve, the filing added.The CMS framework operates under a Coverage with Evidence Development (CED) model, enabling reimbursement with clinical evidence generation.The company said that securing this reimbursement eligibility is expected to facilitate US site activation and accelerate operational momentum across participating centers.The company's shares rose 2% in recent Wednesday trade.
Huaneng Lancang River Hydropower's (SHA:600025) net profit attributable to shareholders for 2025 increased 2.5% to 8.50 billion yuan from 8.30 billion yuan a year earlier, according to a Shanghai bourse filing on Wednesday.Earnings per share rose 2.3% year on year to 0.45 yuan from 0.44 yuan.Operating revenue climbed 6.9% to 26.6 billion yuan from 24.9 billion yuan in the previous year.The hydropower company's shares fell 1% during the morning trade.
Shengyi Technology (SHA:600183) reported a 105.5% jump in attributable net profit in the first quarter to 1.16 billion yuan from 563.6 billion yuan, according to a filing with the Shanghai bourse on Wednesday.Earnings per share doubled to 0.48 yuan from 0.24 yuan.Revenue jumped 45% to 8.14 billion yuan from 5.61 billion yuan, which the electronic components manufacturer attributed to pricing adjustment, among other factors.